Target intelligence / Profile preview

Protein kinase B Pleckstrin Homology domain (Akt PH domain)

Target
Akt PH domain
Molecular classification
Protein domain, Serine/threonine-protein kinase, Signal transduction protein
01

Overview

The Pleckstrin Homology (PH) domain of Protein kinase B (Akt) is a critical regulatory module that mediates the recruitment of the kinase to the plasma membrane (UniProt P31749). This recruitment occurs through high-affinity binding to phosphatidylinositol (3,4,5)-trisphosphate (PIP3) and phosphatidylinositol (3,4)-bisphosphate (PI(3,4)P2), which are generated by Phosphoinositide 3-kinase (PI3K) (PubMed: 22510885). Once localized to the membrane, Akt undergoes conformational changes that allow for its phosphorylation by PDK1 and mTORC2, leading to full activation. Dysregulation of this process, often due to PTEN loss or PI3K mutations, leads to constitutive Akt signaling, a hallmark of many cancers and overgrowth syndromes like Proteus syndrome (PubMed: 21760564). Consequently, the PH domain has emerged as a significant therapeutic target for allosteric inhibitors that prevent membrane translocation or lock the kinase in an inactive conformation. Such inhibitors, including perifosine and miransertib, offer a more selective approach compared to traditional ATP-competitive inhibitors by targeting the unique PH-kinase interface (PubMed: 28137923). However, targeting Akt poses challenges such as systemic hyperglycemia due to the protein's essential role in insulin-mediated glucose uptake (PubMed: 21491404).

Other names
PKB PH domainPleckstrin homology domain of Protein Kinase BAkt PH domainRAC-alpha serine/threonine-protein kinase PH domain
02

Mechanism of action

Allosteric inhibition by binding to the PH domain, preventing membrane translocation, and stabilizing the inactive conformation.

03

Biological functions

Signal transductionCell survivalCell proliferationGlucose metabolismMembrane recruitment
04

Disease associations

CancerProteus syndromePIK3CA-related overgrowth spectrumType 2 diabetes
05

Safety considerations

HyperglycemiaGastrointestinal toxicitySkin rashFatigue
06

Interacting drugs

Perifosine

3 more in the full profile.

07

Biomarkers

AKT1 E17K mutationPTEN lossPIK3CA mutationPhospho-Akt (Ser473/Thr308)

Beyond the preview

Go deeper on Protein kinase B Pleckstrin Homology domain (Akt PH domain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein kinase B Pleckstrin Homology domain (Akt PH domain).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call